Knightsbridge Asset Management »

Horizon Therapeutics shares owned by Knightsbridge Asset Management

Quarter-by-quarter ownership of Horizon Therapeutics shares owned by Knightsbridge Asset Management from 13F filings

Historical chart of Knightsbridge Asset Management investment in Horizon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Horizon Therapeutics held by Knightsbridge Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Horizon Therapeutics by Knightsbridge Asset Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $6.4M 55k 115.70
2023-06-30 $5.7M 55k 102.86

More positions owned by Knightsbridge Asset Management

SPDR Portfolio Large Cap ETF Portfolio S&p500 (SPLG)
Apple (AAPL)
Kraneshares CA Carbon Allowance ETF California Carb (KCCA)
SPDR Portfolio Developed World Ex US ETF Portfolio Devlpd (SPDW)
SPDR Portfolio Emerging Markets ETF PORtFOLIO EMG MK (SPEM)
First Citizens BancShares Cl A (FCNCA)
Celestica Sub Vtg Shs (CLS)
Alphabet Inc Cl A Cap Stk Cl A (GOOGL)
Dimensional US Core Equity 2 Us Core Equity 2 (DFAC)
Parker-Hannifin Corporation (PH)
iShares Core Dividend Growth ETF Core Div Grwth (DGRO)
Visa Com Cl A (V)
Brady Corp Cl A (BRC)
Horizon Therapeutics SHS
CarGurus Com Cl A (CARG)

View all positions for Knightsbridge Asset Management

Top funds holding Horizon Therapeutics

IFP Advisors
Ronald Blue Trust
Beacon Capital Management
Huntington National Bank

View all funds holding Horizon Therapeutics